Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Aimee du Chatinier
Microglia in pediatric brain tumors: The missing link to successful immunotherapy
Keane L. Cheray M. Blomgren K. Joseph B. Multifaceted microglia — key players in primary brain tumour heterogeneity. Nat. Rev. Neurol. 2021; 17: 243-259https://doi.org/10.1038/s41582-021-00463-2 Immune cells and CNS physiology: Microglia and beyond. J. Exp. Med. 2019; 216: 60-70https://doi.org/10.1084/jem.20180199 Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function. Front. Immunol. 2018; 9: 698https://doi.org/10.3389/fimmu.2018.00698 Wake H.
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma Cun Wang1,2, Hui Wang2, Cor Lieftink1, Aimee du Chatinier1, Dongmei Gao3, Guangzhi Jin4, Haojie Jin1,2, Roderick L Beijersbergen1, Wenxin Qin2, René Bernards1 1 Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands 2 State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai...
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma Cun Wang1,2, Hui Wang2, Cor Lieftink1, Aimee du Chatinier1, Dongmei Gao3, Guangzhi Jin4, Haojie Jin1,2, Roderick L Beijersbergen1, Wenxin Qin2, René Bernards1 1Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands 2State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao...
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma Cun Wang1,2, Hui Wang2, Cor Lieftink1, Aimee du Chatinier1, Dongmei Gao3, Guangzhi Jin4, Haojie Jin1,2, Roderick L Beijersbergen1, Wenxin Qin2, René Bernards1 1Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands 2State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Aimee
Contact Aimee, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack